Total planned funding: $87,037,142
Allocations
Countries/Regions
India | $87,037,142 |
Organizational Types
Unknown | $34,144,299 |
NGO | $23,996,216 |
Own Agency | $16,686,627 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $2,660,000 |
University | $2,600,000 |
Private Contractor | $1,650,000 |
FBO | $1,600,000 |
Host Country Government Agency | $600,000 |
Program Areas
Governance and Systems | $39,670,191 |
Prevention | $18,740,492 |
Management and Operations | $11,980,158 |
Care | $7,604,767 |
Treatment | $5,545,977 |
Testing | $3,495,557 |
Budget Codes
OHSS: Health Systems Strengthening | $21,180,434 |
HVSI: Strategic Information | $14,643,773 |
HVMS: Management and Operations | $11,980,158 |
HVOP: Sexual Prevention: Other Sexual Prevention | $9,547,656 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,153,396 |
HTXS: Treatment: Adult Treatment | $5,039,482 |
HLAB: Laboratory Infrastructure | $3,845,984 |
HVCT: Testing: HIV Testing and Counseling | $3,495,557 |
HVTB: Care: TB/HIV | $2,924,422 |
HBHC: Care: Adult Care and Support | $2,705,604 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $1,688,556 |
HKID: Care: Orphans and Vulnerable Children | $1,632,708 |
HMBL: Biomedical Prevention: Blood Safety | $1,299,653 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,051,231 |
PDTX: Treatment: Pediatric Treatment | $483,018 |
PDCS: Care: Pediatric Care and Support | $342,033 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$34,144,299
Countries/Regions
FHI 360:
$13,825,228
Countries/Regions
USG Aggregated Agencies:
$11,570,590
Countries/Regions
Voluntary Health Services:
$3,150,000
Countries/Regions